With the popularity of cervical cancer screening, more and more precancerous lesions are being screened for. However, at the same time, it creates undue stress for patients. There are standard treatment protocols for the management of cervical lesions. Some of the 2006 American Society for Colposcopy and Cervical Pathology treatment guidelines are briefly described. The most commonly used cervical cancer screening test is cervical thin-layer liquid-based cytology, and the most commonly reported abnormality in the outpatient setting is atypical squamous epithelial cells (ASC), which is divided into atypical squamous epithelial cells of uncertain significance (ASC-US) and atypical squamous epithelial cells without high-grade intraepithelial neoplasia (ASC-H). In addition, for LSIL, HSIL.